Model 2002 Maestro Rechargeable Neuroregulator - The Model 2002 Rechargeable Neuroregulator (RNR) - Reshape Lifesciences Inc.

Duns Number:144998551

Device Description: The Model 2002 Rechargeable Neuroregulator (RNR) is provided sterile for implantation and The Model 2002 Rechargeable Neuroregulator (RNR) is provided sterile for implantation and has a hermetic case enclosure with an integrated coil that acts as an antenna for telemetry and recharging. The RNR is surgically implanted to deliver electrical current to the implanted leads. It contains a rechargeable battery which is charged transcutaneously using a Transmit Coil.

Want to know more about this Product? Request more information now!


More Product Details

Catalog Number

2002

Brand Name

Model 2002 Maestro Rechargeable Neuroregulator

Version/Model Number

2002

Device Commercial Distribution Status

Not in Commercial Distribution

Commercial Distribution End Date

June 01, 2019

Issuing Agency

In GS1

Product Characteristics

MRI safety Status

MR Unsafe

Device required to be labeled as containing natural rubber latex or dry natural rubber (21 CFR 801.437)

-

Device labeled as "Not made with natural rubber latex"

-

For Single-Use

Yes

Prescription Use (Rx)

Yes

Over the Counter (OTC)

-

Kit

-

Combination Product

-

Human Cell, Tissue or Cellular or Tissue-Based Product (HCT/P)

-

FDA Premarket Submission

P130019

Product Code Details

Product Code

PIM

Product Code Name

neuromodulator for obesity

Device Record Status

Public Device Record Key

e8b659cd-a553-4204-8ae6-c5f161779c3c

Public Version Date

September 17, 2020

Public Version Number

5

DI Record Publish Date

April 17, 2015

Additional Identifiers

Package DI Number

None

Quantity per Package

-

Contains DI Package

-

Package Discontinue Date

-

Package Status

-

Package Type

-

"RESHAPE LIFESCIENCES INC." Characteristics
Device Class Device Class Description No of Devices
2 A medical device with a moderate to high risk that requires special controls. 4
3 A medical device with high risk that requires premarket approval 20